A 3D Model of the Human Lung Airway for Evaluating Permeability of Inhaled Drugs

Current in vitro cell-based methods, relying on single cell types, have structural and functional limitations in determining lung drug permeability, which is a contributing factor affecting both local and systemic drug levels. To address this issue, we investigated a 3D human lung airway model generated using a cell culture insert, wherein primary human lung epithelial and endothelial cells were cocultured at an air-liquid interface (ALI). To ensure that the cell culture mimics the physiological and functional characteristics of airway tissue, the model was characterized by evaluating several parameters such as cellular confluency, ciliation, tight junctions, mucus-layer formation, transepithelial electrical resistance, and barrier function through assaying fluorescein isothiocyanate-dextran permeability. To understand how the characterized ALI quality attributes influenced the absorption of inhaled drugs through the epithelial-endothelial barrier, we measured the permeability and epithelial intracellular concentrations of albuterol sulfate (AL), formoterol fumarate (FO), and fluticasone furoate (FL). The presented characterization results overall demonstrate that this culture platform mimicked the airway-specific structure and barrier function. An apparent permeability (<i>P</i> <sub>app</sub>) of 5.7 × 10<sup>-6</sup> cm/s and an intracellular concentration below 1% were quantified for AL over 3 h. The <i>P</i> <sub>app</sub> of FO was 8.5 × 10<sup>-6</sup> cm/s, with an intracellular concentration of 3.8%. Due to its high lipophilicity, FL showed a higher intracellular concentration (17.4%) compared to AL and FO, but also a 73.1% loss of the compound over 3 h due to nonspecific binding, with a <i>P</i> <sub>app</sub> as low as 1.3 × 10<sup>-7</sup> cm/s. While the model exhibited physiologically relevant properties, its utility in estimating the permeability of inhaled drugs may be drug-specific, warranting further optimization and study.

Authors

Institutions

Publication Details

Journal
ACS Pharmacology & Translational Science
Published
2024-12-29
DOI
https://doi.org/10.1021/acsptsci.4c00607
Citations
2
Primary Topic
Inhalation and Respiratory Drug Delivery
Type
article
Field-Weighted Citation Impact
0.84

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A 3D Model of the Human Lung Airway for Evaluating Permeability of Inhaled Drugs

Shekh M Rahman, Paula L. Hyland, Alexandre J. S. Ribeiro, Omnia A. Ismaiel et al.
2 citations
ACS Pharmacology & Translational Science
Inhalation and Respiratory Drug Delivery
0.84
article

A 3D Model of the Human Lung Airway for Evaluating Permeability of Inhaled Drugs

Shekh M Rahman, Paula L. Hyland, Alexandre J. S. Ribeiro, Omnia A. Ismaiel, Murali K. Matta, Jeffrey Florian, Isra Tariq, Bryan Newman, M. S. Rashid Roni, Katherine Shea, Dieter Brückner, Ross Walenga, Kevin A. Ford, Robert Geiger, Ksenia Blinova, Wenlei Jiang
article en
2 citations

Abstract

Current in vitro cell-based methods, relying on single cell types, have structural and functional limitations in determining lung drug permeability, which is a contributing factor affecting both local and systemic drug levels. To address this issue, we investigated a 3D human lung airway model generated using a cell culture insert, wherein primary human lung epithelial and endothelial cells were cocultured at an air-liquid interface (ALI). To ensure that the cell culture mimics the physiological and functional characteristics of airway tissue, the model was characterized by evaluating several parameters such as cellular confluency, ciliation, tight junctions, mucus-layer formation, transepithelial electrical resistance, and barrier function through assaying fluorescein isothiocyanate-dextran permeability. To understand how the characterized ALI quality attributes influenced the absorption of inhaled drugs through the epithelial-endothelial barrier, we measured the permeability and epithelial intracellular concentrations of albuterol sulfate (AL), formoterol fumarate (FO), and fluticasone furoate (FL). The presented characterization results overall demonstrate that this culture platform mimicked the airway-specific structure and barrier function. An apparent permeability (<i>P</i> <sub>app</sub>) of 5.7 × 10<sup>-6</sup> cm/s and an intracellular concentration below 1% were quantified for AL over 3 h. The <i>P</i> <sub>app</sub> of FO was 8.5 × 10<sup>-6</sup> cm/s, with an intracellular concentration of 3.8%. Due to its high lipophilicity, FL showed a higher intracellular concentration (17.4%) compared to AL and FO, but also a 73.1% loss of the compound over 3 h due to nonspecific binding, with a <i>P</i> <sub>app</sub> as low as 1.3 × 10<sup>-7</sup> cm/s. While the model exhibited physiologically relevant properties, its utility in estimating the permeability of inhaled drugs may be drug-specific, warranting further optimization and study.

ACS Pharmacology & Translational ScienceVol. 8(1)
United States Food and Drug Administration (US), Booz Allen Hamilton (United States) (US), Center for Drug Evaluation and Research (US)
U.S. Department of Energy, U.S. Food and Drug Administration, Oak Ridge Institute for Science and Education
Good health and well-being
Openalex Percentile: Top 22%
Inhalation and Respiratory Drug Delivery
0.84
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.